๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI ยท Real-Time Price ยท USD
7.06
-0.14 (-1.88%)
Nov 20, 2026, 11:22 AM EST - Market open

MRVI Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
213185.74259.19288.95883799.24
Revenue Growth
10.69%-28.34%-10.30%-67.28%10.48%181.32%
Gross Profit
85.0935.69108.31140.2714.04658.68
Operating Income
-51.53-125.63-72.68-28.47569.92543.4
Net Income
-65.67-130.77-144.85-119.03220.21182.04
Earnings Per Share
-0.45-0.91-1.05-0.901.671.56
EPS Growth
----6.97%-33.73%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
TriLink
145.09119.79196.35224.77813.08712.52
Cygnus
67.965.9662.8464.1869.9368.42
Total
213185.74259.19288.95883799.24

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
73.02216.89323.77574.96632.14551.27
Total Debt
225.9364.71376.69610.97585.26575.22
Net Cash (Debt)
-152.87-147.82-52.92-36.0146.88-23.95
Net Cash Growth
------
Net Cash Per Share
-1.04-1.02-0.38-0.270.18-0.09

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.1-57.577.47126.22535.98368.57
Capital Expenditures
-8.18-13.15-29.66-65.55-17.09-14.85
Free Cash Flow
-13.27-70.72-22.1960.67518.89353.72
Free Cash Flow Growth
----88.31%46.69%179.00%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.95%19.21%41.79%48.52%80.87%82.41%
Operating Margin
-24.19%-67.64%-28.04%-9.85%64.54%67.99%
Pretax Margin
-54.19%-126.50%-100.89%213.79%62.45%66.41%
Profit Margin
-30.83%-70.41%-55.88%-41.19%24.94%22.78%
FCF Margin
-6.23%-38.07%-8.56%21.00%58.76%44.26%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----8.5530.26
Forward PE
-126.02126.02207.0523.4242.82
P/FCF Ratio
---14.273.6315.57
PS Ratio
8.772.542.983.002.136.89